ENTRY       D10461            Mixture   Drug
NAME        Dienogest and estradiol valerate;
            Natazia (TN)
PRODUCT     NATAZIA (Bayer HealthCare Pharmaceuticals)
  GENERIC   ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST (Sandoz)
COMPONENT   Dienogest [DR:D03799], Estradiol valerate [DR:D01413]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      ATC code: G03AB08
            Product: D10461<US>
EFFICACY    Contraceptive
COMMENT     Combination of estrogen and progestin
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
                G03AB Progestogens and estrogens, sequential preparations
                 G03AB08 Dienogest and estradiol
                  D10461  Dienogest and estradiol valerate &lt;US&gt;
            USP drug classification [BR:br08302]
             Contraceptives
              Oral Contraceptives Combinations
               Estradiol Valerate/ Dienogest
                D10461  Dienogest and estradiol valerate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10461  Dienogest and estradiol valerate
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10461
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10461
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10461
DBLINKS     PubChem: 172232554
///
